Kaiser Corporation Limited received no complaints regarding its proposed scheme of amalgamation with Emazing Deals Limited. The company confirmed this in a report submitted to the BSE, marking a clean regulatory review of the merger proposal.

The company filed the report under Regulation 37 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This submission complies with Para I(A)(6) of the SEBI Master Circular dated December 22, 2020. The circular mandates that companies disclose any complaints received from shareholders or other stakeholders during the public objection period for draft schemes.

Complaints Report Details

The draft scheme was uploaded to the BSE website on September 2, 2026. The statutory period for accepting complaints lasted for 21 days, expiring on September 23, 2026. Kaiser Corporation submitted its report within seven days of this expiry, as required by regulatory norms.

The attached report indicated that no complaints were received directly by the company. Additionally, no complaints were forwarded by the stock exchange during this window. Consequently, the total number of complaints or comments stood at nil.

Regulatory Compliance

Kaiser Corporation also uploaded the report on its official website to ensure transparency. The company requested the BSE to take the submission on record as compliance with applicable SEBI regulations. Jinal Jain, Company Secretary and Compliance Officer, signed the document.

The scheme involves the amalgamation of Emazing Deals Limited, designated as the Transferor Company, with Kaiser Corporation Limited, the Transferee Company. With no objections raised by stakeholders, the procedural step for public feedback is complete. The next stages will involve approvals from the National Company Law Tribunal and respective shareholders.

Kaiser Corporation reported a consolidated net loss of ₹200.44 lakh for FY26, widening slightly from the ₹196.77 lakh loss in FY25. The decline was driven by a sharp drop in revenue and increased overheads.

Total income for the group fell to ₹1,525.53 lakh from ₹2,173.80 lakh in the previous year. While other income rose to ₹374.28 lakh, it could not offset the steep fall in sales revenue, which dropped to ₹1,151.25 lakh from ₹1,979.98 lakh. Finance costs increased to ₹204.21 lakh from ₹189.93 lakh, further pressuring margins.

Standalone Performance

In contrast to the consolidated results, the standalone entity posted a net profit of ₹8.25 lakh, up from ₹6.09 lakh in FY25. Standalone total income grew marginally to ₹82.59 lakh from ₹73.25 lakh. The company did not recommend any dividend for the year ended March 31, 2026.

Financial Highlights

Corporate Governance & AGM

The company scheduled its 33rd Annual General Meeting for September 28, 2026. Key agenda items include the re-appointment of Managing Director Mr. Bhushanlal Arora and the appointment of Ms. Kavita Sharma as Whole Time Director effective July 28, 2026. M/s. Ganesh & Rajendra Associates is proposed as Statutory Auditors for five years from FY27.

What the Numbers Show

The divergence between the standalone profit and consolidated loss highlights the subsidiary's impact on overall performance. While the parent company remains profitable, the group's financial health is weighed down by higher finance costs and reduced sales volume at the consolidated level.